DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
当前地点:
>
> This Story


注册记数器 to rate this News Story
Forward Printable StoryPrint Comment

 

MRI Homepage

MR imaging breaks new ground for depression and anxiety research Shows structural similarities and differences

Elekta to add functional imaging capabilities and take more time to validate MR-linac system Expects CE approval in first half of 2018

Aspect Imaging scores CE mark for its Embrace Neonatal MR system Already in use in Israel

Updated guidelines recommend use of S-ICDs for patients with ventricular arrhythmia Call to action for physicians

Study cautions against trust in MR results for axial spondyloarthritis MR scans are prone to produce positive results for axSpA in healthy individuals

Mallinckrodt Institute of Radiology installs first Siemens MAGNETOM Vida in the US First Siemens MR scanner to carry BioMatrix technology

MR study shows how different football positions impact brain damage First time DTI and fMRI used in conjunction

Action star Chuck Norris, wife Gena, sue eleven organizations over gadolinium Allege MR contrast agent 'nearly killed her'

Swedish researchers map brains of patients with prosthetic limbs using 7T MR Progress in pursuit of fake limbs that feel real

Using functional MR to predict suicidal tendencies Revealing alterations in brain patterns in response to concepts such as death, cruelty, and trouble

FDA panel: Add retention warning to gadolinium contrast agents

Thomas Dworetzky , Contributing Reporter
The gadolinium safety debate took another turn Friday, when the FDA's Medical Imaging Drugs Advisory Committee (MIDAC) voted to recommend revisions to the prescribing information for MR contrast agents with the material.

The vote was to add a warning that gadolinium can be retained in some organs and tissues.

Story Continues Below Advertisement

The (#1 Resource) for Medical Imaging and Peripherals. Call 1-949-273-8000

As a Master Distributor for major brands Barco, Philips, and Sony, we offer custom imaging solutions. With our renowned OEM Solutions and Service/Repair Center, Ampronix is a one-stop shop for HD Medical LCD Displays--Printers--Recorders--4K Cameras



According to a response to the meeting by Guerbet, “There are two kinds of gadolinium based contrast agents [GBCAs], linear and macrocyclic. Although there are many similarities amongst these agents, they differ in their kinetic and thermodynamic stability. Linear GBCAs are generally less stable, and for this reason, more likely than macrocyclic agents to deposit gadolinium in tissue. Guerbet's GBCA, Dotarem [gadoterate meglumine] is a macrocyclic agent. The advisory would also state the risk of retention is slightly greater with linear agents versus macrocyclic ones.”

At the meeting, 13 committee members voted in favor of the proposal. "It was appropriate to state that there may be differences among these agents that need to be explored," said one, Dr. Michael Weisman, a professor of medicine at the University of California, Los Angeles, adding that, "It's also appropriate to state that risk strategies need to be looked at more carefully. There are populations that need to be addressed, such as those that may overutilize this type of contrast imaging."

The strongest – and only – dissenting vote came from Alicia Toledano, who is president of Biostatistics Consulting in Kensington, MD. She felt it did not go far enough.

"It is hard to dismiss an anecdotal report when you are the anecdote. A life ruined is a life ruined," she said. "What does a patient do when doctors and everyone she or he turns to for help 'pooh-poohs' his or her concerns and does not order a simple urine test? When a patient finally gets tested and is found to have gadolinium retention, there is no FDA-approved antidote. What does that patient do?"

She called the proposal “insufficient.”



The group was also unanimous at 15-0 in its vote requiring the agency to have contrast manufacturers do more studies to see if more regulation is necessary.

The group argued that more information is vital.

"It's clear we need more information," stated Dr. Peter Herscovitch, acting MIDAC chair and director of the PET department at the U.S. National Institutes of Health (NIH).

The votes followed a public hearing on retention that saw many emotional moments about adverse reactions, including from a representative of Gena Norris, the wife of famed action-star Chuck Norris. After a series of scans with gadolinium, she suffered severe abdominal pain.

She has resorted to treating her condition with an expensive professional hyperbaric chamber.

"My heart breaks for those who don't have the financial means they need," she added. "We will continue to use our platform to raise awareness about the dangers of gadolinium."

That said, despite the risks of retention, Dr. Elizabeth Morris, past president of the Society of Breast Imaging and a breast radiologist at Memorial Sloan Kettering Cancer Center, called its use essential and a “lifesaving test."

Also advising caution against an overreaction, Dr. Scott Reeder, of the University of Wisconsin, advised that, "it is important to consider the importance of the benefits of gadolinium in treating patients with a wide variety of diseases, as well as the standard safety record of these agents."

MRI Homepage


You Must Be Logged In To Post A Comment

做广告
提升您的品牌知名度
拍卖+私人销售
获得最好的价格
买设备/配件
找到最低价格
每日新闻
阅读最新信息
目录
浏览所有的DOTmed用户
DOTmed上的伦理
查看我们的伦理计划
金子分开供营商节目
接收PH要求
金子服务经销商节目
接收请求
提供保健服务者
查看所有的HCP(简称医疗保健提供商)的工具
工作/训练
查找/申请工作
Parts Hunter +EasyPay
获取配件报价
最近证明
查看最近通过认证的用户
最近额定
查看最近通过认证的用户
出租中央
租用设备优惠
卖设备/配件
得到最划算
服务技术员论坛
查找帮助和建议
简单的征求建议书
获取设备报价
真正商业展览
查找对设备的服务
对这个站点的通入和用途是受期限和条件我们支配 法律公告 & 保密性通知
物产和业主对 DOTmed.com,公司 Copyright ©2001-2017 DOTmed.com, Inc.
版权所有